Evidence for microsatellite instability in bilateral breast carcinomas

Cancer Letters

Volumn 154, Issue 1, 2000, Pages 9-17

  Imyanitov, Evgeny N ^a,b   Togo, Alexander V ^a   Suspitsin, Evgeny N ^a   Grigoriev, Maxim Y ^a   Pozharisski, Kazimr M ^a   Turkevich, Elena A ^a   Hanson, Kaido P ^a   Hayward, Nicholas K ^b   Chenevix Trench, Georgia ^a   Theillet, Charles ^c   Lavin, Martin F ^b,d  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bilateral breast cancer; Loss of heterozygosity; Microsatellite instability

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 5Q; CHROMOSOME REPLICATION; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOME DELETION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 0034212161     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00444-9     Document Type: Article

References (33)

1. Hulka B.S. Epidemiology of susceptibility to breast cancer. Prog. Clin. Biol. Res. 395:1996;159-174.
2. Leis H.P. Bilateral breast cancer. Surg. Clin. North Am. 58:1978;833-841.
3. Chaudary M.A., Millis R.R., Hoskins E.O., Halder M., Bulbrook R.D., Cuzick J., Hayward J.L. Bilateral primary breast cancer: a prospective study of disease incidence. Br. J. Surg. 71:1984;711-714.
4. Donovan A.J. Bilateral breast cancer. Surg. Clin. North Am. 70:1970;1141-1149.
5. Hislop T.G., Elwood J.M., Coldman A.J., Spinelli J.J., Worth A.J., Ellison L.G. Second primary cancers of the breast: incidence and risk factors. Br. J. Cancer. 49:1984;79-85.
6. Gulay H., Hamaloglu E., Bulut O., Goksel H.A. Bilateral breast carcinoma. 28 years experience. World J. Surg. 14:1990;529-533.
7. Bernstein J.L., Thompson W.D., Risch N., Holford T.R. The genetic epidemiology of second primary breast cancer. Am. J. Epidemiol. 136:1992;937-948.
8. Graham M.D., Yelland A., Peacock J., Beck N., Ford H., Gazet J.C. Bilateral carcinoma of the breast. Eur. J. Surg. Oncol. 19:1993;259-264.
9. Gogas J., Markopoulos C., Skandalakis P., Gogas H. Bilateral breast cancer. Am. Surg. 59:1993;733-735.
10. Green M.H. Genetics of breast cancer. Mayo Clin. Proc. 72:1997;54-65.
11. Devilee P., Cornelisse C.J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta. 1198:1994;113-130.
12. Zhou X.P., Hoang J.M., Li Y.J., Seruca R., Carneiro F., Sobrinho-Simoes M., Lothe R.A., Gleeson C.M., Russell S.E., Muzeau F., Flejou J.F., Hoang-Xuan K., Lidereau R., Thomas G., Hamelin R. Determination of the replication error phenotype in human tumours without the requirement from matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer. 21:1998;101-110.
13. Parsons R., Myeroff L.L., Liu B., Willson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:1995;5548-5550.
14. Gryfe R., Swallow C., Bapat B., Redston M., Gallinger S., Couture J. Molecular biology of colorectal cancer. Curr. Probl. Cancer. 21:1997;233-300.
15. Oda S., Oki E., Maehara Y., Sugimachi K. Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res. 25:1997;3415-3420.
16. Jiricny J. Mismatch repair and cancer. Cancer Surv. 28:1996;47-68.
17. Dillon E.K., de Boer W.B., Papadimitriou J.M., Turbett G.R. Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br. J. Cancer. 76:1997;156-162.
18. Niederacher D., Picard F., van Roeyen C., An H.X., Bender H.G., Beckmann M.W. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer. 18:1997;181-192.
19. Yee C.J., Roodi N., Verrier C.S., Parl F.F. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 54:1994;1641-1644.
20. Ackerman J., Baunoch D.A., Gimotty P., George J., Lane M.A., Dawson P.J. The role of p53 mutations in bilateral breast carcinomas. Mod. Pathol. 8:1995;244-248.
21. Jost C.A., Marin M.C., Kaelin W.G. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
22. Imyanitov E.N., Birrell G.W., Filippovich I., Sorokina N., Arnold J., Mould M.A., Wright K., Walsh M., Mok S.C., Lavin M.F., Chenevix-Trench G., Khanna K.K. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene coding p73 is unlikely to be the target. Oncogene. 18:1999;4640-4642.
23. Vorechovsky I., Luo L., Dyer M.J., Catovsky D., Amlot P.L., Yaxley J.C., Foroni L., Hammarstrom L., Webster A.D., Yuille M. Clustering of missence mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat. Genet. 17:1997;96-99.
24. Stankovic T., Weber P., Stewart G., Bedenham T., Murray J., Byrd P.J., Moss P.A.H., Taylor A.M.R. Inactivation of ataxia-telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 353:1999;26-29.
25. Wooster R., Neuhausen S.I., Mangion J.L., Quirk Y., Ford D., Collins N., Nguyen K., Seal K.S., Tran T., Averill D., et al. Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13. Science. 265:1994;2088-2090.
26. Bailey M.J., Royce C., Sloane J.P., Ford H.T., Powles T., Gazet J.C. Bilateral carcinoma of the breast. Br. J. Surg. 67:1980;514-516.
27. Aaltonen A., Peltomäki P., Leach F.S., Sitonen P., Pylkkänen L., Mecklin J.P., Järvinen H., Powell S.N., Jen J., Hamilton S.P., Petersen G., Kinzler K.W., Vogelstein B., de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
28. Fishel R., Lescoe M.K., Rao M.R.S., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell. 75:1993;1027-1038.
29. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Nadia G., anzani R., Srivastava S. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the detection of microsatellite instability in colorectal cancer. Cancer Res. 58:1998;5248-5257.
30. Shibata A., Tsai Y.C., Press M.F., Henderson B.E., Jones P.A., Ross R. Clonal analysis of bilateral breast cancer. Clin. Cancer Res. 2:1996;743-748.
31. Ozer E., Canda T., Kuyucuoolu F. p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume. Cancer Lett. 122:1998;101-106.
32. Greenwald B.D., Harpaz N., Yin J., Huang Y., Tong Y., Brown V.L., McDaniel T., Newkirk C., Resau J.H., Meltzer S.J. Loss of heterozygosity affecting the p53 Rb, and mcc.apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res. 52:1992;741-745.
33. Futreal P.A., Barrett J.C., Wiseman R.W. An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res. 19:1991;6977.